newsfilter
← Latest News
FDA Approved Drugs·

Approval of Camzyos, Nda #214998 (Type 1 - New Molecular Entity)

Approval Date: 04/28/2022; Drug Name: Camzyos, Nda #214998; Active Ingredients: MAVACAMTEN; Company: Myokardia Inc; Submission Status: Approval; Submission Classification: Type 1 - New Molecular Entity; Application Number: 214998

Company
MYOKARDIA INC
Keywords
MYOKARDIA INC